Kinase-dependent pathways and the development of insulin resistance in hepatocytes

References

• Kahn BB. Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell92, 593–596 (1998).
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature414, 782–787 (2001).
   PubMed Web of Science ®Google Scholar
• Kahn BB, Flier JS. Obesity and insulin resistance. J. Clin. Invest.106, 473–481 (2000).
   PubMed Web of Science ®Google Scholar
• Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature414, 799–806 (2001).
   PubMed Web of Science ®Google Scholar
• Liu Z, Barrett EJ. Human protein metabolism: its measurement and regulation. Am. J. Physiol. Endocrinol. Metab.283, E1105–E1112 (2002).
   Google Scholar
• Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature404, 661–671 (2000).
   PubMed Web of Science ®Google Scholar
• Obici S, Rossetti L. Minireview: nutrient sensing and the regulation of insulin action and energy balance. Endocrinology144, 5172–5178 (2003).
   PubMed Web of Science ®Google Scholar
• Kitamura T, Kahn CR, Accili D. Insulin receptor knockout mice. Annu. Rev. Physiol.65, 313–332 (2003).
   PubMed Web of Science ®Google Scholar
• Michael MD, Kulkarni RN, Postic C et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell.6, 87–97 (2000).
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Bruning JC, Winnay JN et al. Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell96, 329–339 (1999).
   PubMed Web of Science ®Google Scholar
• Bruning JC, Gautam D, Burks DJ et al. Role of brain insulin receptor in control of body weight and reproduction. Science289, 2122–2155 (2000).
   PubMed Web of Science ®Google Scholar
• Paquot N, Scheen AJ, Dirlewanger M, Lefebvre PJ, Tappy L. Hepatic insulin resistance in obese non-diabetic subjects and in Type 2 diabetic patients. Obes. Res.10,129–134 (2002).
   Google Scholar
• Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes45, 633–638 (1996).
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care14, 173–194 (1991).
   PubMed Web of Science ®Google Scholar
• Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism33, 68–75 (1984).
   PubMed Web of Science ®Google Scholar
• Golay A, Chen N, Chen YD, Hollenbeck C, Reaven GM. Effect of central obesity on regulation of carbohydrate metabolism in obese patients with varying degrees of glucose tolerance. J. Clin. Endocrinol. Metab.71, 1299–1304 (1990).
   Google Scholar
• Hotamisligil GS. Mechanisms of TNF-α-induced insulin resistance. Exp. Clin. Endocrinol. Diabetes107, 119–125 (1999).
   PubMed Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature409, 307–312 (2001).
   PubMed Web of Science ®Google Scholar
• Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med.7, 947–953 (2001).
   PubMed Web of Science ®Google Scholar
• Bergman RN, Ader M. Free fatty acids and pathogenesis of Type 2 diabetes mellitus. Trends Endocrinol. Metab.11, 351–356 (2000).
   PubMed Web of Science ®Google Scholar
• Bjorntorp P. ‘Portal’ adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis10, 493–496 (1990).
   PubMedGoogle Scholar
• Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes46, 3–10 (1997).
   PubMed Web of Science ®Google Scholar
• Byrne CD, Wareham NJ, Brown DC et al. Hypertriglyceridaemia in subjects with normal and abnormal glucose tolerance: relative contributions of insulin secretion, insulin resistance and suppression of plasma non-esterified fatty acids. Diabetologia37, 889–896 (1994).
   Google Scholar
• Fraze E, Donner CC, Swislocki AL, Chiou YA, Chen YD, Reaven GM. Ambient plasma free fatty acid concentrations in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. J. Clin. Endocrinol. Metab.61, 807–811 (1985).
   PubMed Web of Science ®Google Scholar
• Chu CA, Sherck SM, Igawa K et al. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs. Am. J. Physiol. Endocrinol. Metab.282, E402–E411 (2002).
   PubMedGoogle Scholar
• Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G, Olefsky JM. Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation. J. Clin. Endocrinol. Metab.87, 226–234 (2002).
   PubMed Web of Science ®Google Scholar
• Lam TK, van de WG, Giacca A. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites. Am. J. Physiol. Endocrinol. Metab.284, E281–E290 (2003).
   PubMed Web of Science ®Google Scholar
• Roden M, Stingl H, Chandramouli V et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes49, 701–707 (2000).
   PubMed Web of Science ®Google Scholar
• Ye JM, Frangioudakis G, Iglesias MA et al. Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver. Endocrinology143, 4527–4535 (2002).
   Google Scholar
• Stingl H, Krssak M, Krebs M et al. Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia44, 48–54 (2001).
   PubMedGoogle Scholar
• Hegarty BD, Cooney GJ, Kraegen EW, Furler SM. Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes51, 1477–1484 (2002).
   PubMed Web of Science ®Google Scholar
• Mithieux G, Guignot L, Bordet JC, Wiernsperger N. Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes51, 139–143 (2002).
   Web of Science ®Google Scholar
• Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes46, 1768–1774 (1997).
   PubMed Web of Science ®Google Scholar
• Ostman J, Arner P, Engfeldt P, Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism28, 1198–1205 (1979).
   PubMed Web of Science ®Google Scholar
• Williamson JR. Mechanism for the stimulation in vivo of hepatic gluconeogenesis by glucagon. Biochem. J.101, 11C–14C (1966).
   PubMed Web of Science ®Google Scholar
• Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a mechanism to improve energy balance and insulin resistance. Br. J. Nutr.83(Suppl. 1) S59–S66 (2000).
   PubMed Web of Science ®Google Scholar
• Xu J, Nakamura MT, Cho HP, Clarke SD. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J. Biol. Chem.274, 23577–23583 (1999).
   PubMed Web of Science ®Google Scholar
• Mittelman SD, Van Citters GW, Kim SP et al. Longitudinal compensation for fat-induced insulin resistance includes reduced insulin clearance and enhanced β-cell response. Diabetes49, 2116–2125 (2000).
   PubMed Web of Science ®Google Scholar
• Rebrin K, Steil G, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest.98, 741–749 (1996).
   PubMed Web of Science ®Google Scholar
• Boden G, Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J. Clin. Invest.96, 1261–1268 (1995).
   PubMed Web of Science ®Google Scholar
• Shulman GI. Cellular mechanisms of insulin resistance. J. Clin. Invest.106, 171–176 (2000).
   PubMed Web of Science ®Google Scholar
• Anai M, Funaki M, Ogihara T et al. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes47, 13–23 (1998).
   PubMed Web of Science ®Google Scholar
• Kim JK, Fillmore JJ, Chen Y et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc. Natl Acad. Sci. USA98, 7522–7527 (2001).
   PubMed Web of Science ®Google Scholar
• Samuel VT, Liu ZX, Qu X et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem.279, 32345–32353 (2004).
   PubMed Web of Science ®Google Scholar
• Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev.81, 807–869 (2001).
   PubMed Web of Science ®Google Scholar
• Callejo AI, Casanova E, Calvo P, Galetto R, Rodriguez-Rey JC, Chinchetru MA. Characterization of the promoter of the mouse c-Jun NH2-terminal/stress-activated protein kinase α gene. Biochim. Biophys. Acta1681, 47–52 (2004).
   Google Scholar
• Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK) – from inflammation to development. Curr. Opin. Cell Biol.10, 205–219 (1998).
   PubMed Web of Science ®Google Scholar
• Hirosumi J, Tuncman G, Chang L et al. A central role for JNK in obesity and insulin resistance. Nature420, 333–336 (2002).
   PubMed Web of Science ®Google Scholar
• Aguirre V, Uchida T, Yenush L, Davis RJ, White MF. The c-Jun NH2-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser307.J. Biol. Chem.275, 9047–9054 (2000).
   PubMed Web of Science ®Google Scholar
• Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisgilil GS. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proc. Natl. Acad. Sci. USA103, 10741–10746 (2006).
   PubMed Web of Science ®Google Scholar
• Liu H, Jones BE, Bradham C, Czaja MJ. Increased cytochrome P-450 2E1 expression sensitizes hepatocytes to c-Jun-mediated cell death from TNF-α. Am. J. Physiol. Gastrointest. Liver Physiol.282, G257–G266 (2002).
   Google Scholar
• Liu H, Lo CR, Czaja MJ. NF-κB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology35, 772–778 (2002).
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Uchinami H, Qian T, Bennett BL, Lemasters JJ, Brenner DA. Differential requirement for c-Jun NH2-terminal kinase in TNF- and Fas-mediated apoptosis in hepatocytes. FASEB J.18, 720–722 (2004).
   PubMedGoogle Scholar
• Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J. Clin. Invest.105, 1067–1075 (2000).
   PubMed Web of Science ®Google Scholar
• Ozcan U, Cao Q, Yilmaz E et al. Endoplasmic reticulum stress links obesity, insulin action, and Type 2 diabetes. Science306, 457–461 (2004).
   PubMed Web of Science ®Google Scholar
• Nakatani Y, Kaneto H, Kawamori D et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem.280, 847–851 (2005).
   PubMed Web of Science ®Google Scholar
• Schattenberg JM , Singh R, Wang Y et al. Jnk1 but not jnk2 promotes the development of steatohepatitis in mice. Hepatology43, 163–172 (2006).
   PubMed Web of Science ®Google Scholar
• Radziuk J, Bailey CJ, Wiernsperger NF, Yudkin JS. Metformin and its liver targets in the treatment of Type 2 diabetes. Curr. Drug Targets Immune Endocr. Metabol. Disord.3, 151–169 (2003).
   PubMedGoogle Scholar
• Kumar N, Dey CS. Metformin enhances insulin signalling in insulin-dependent and -independent pathways in insulin resistant muscle cells. Br. J. Pharmacol.137, 329–336 (2002).
   PubMed Web of Science ®Google Scholar
• Cleasby ME, Dzamko N, Hegarty BD, Cooney GJ, Kraegen EW, Ye JM. Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. Diabetes53, 3258–3266 (2004).
   PubMed Web of Science ®Google Scholar
• Lam TKT, Yoshii H, Haber A, Bogdanovic Lam L, Fantus G, Giacca A. Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ. Am J Physiol283: E682–E691 (2002).
   Google Scholar
• Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J.9, 484–496 (1995).
   PubMed Web of Science ®Google Scholar
• Itani SI, Ruderman NB, Schmieder, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IκB-α. Diabetes51, 2005–2011 (2002).
   Google Scholar
• Bell KS, Schmitz-Peiffer C, Lim-Fraser M, Biden TJ, Cooney GJ, Kraegen EW. Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-theta localization. Am. J. Physiol. Endocrinol. Metab.279, E1196–E1201 (2001).
   Google Scholar
• Heydrick SJ, Ruderman NB, Kurowski TG, Adams HB, Chen KS. Enhanced stimulation of diacylglycerol and lipid synthesis by insulin in denervated muscle: altered protein kinase C activity and possible link to insulin resistance. Diabetes40, 1707–1711 (1991).
   PubMed Web of Science ®Google Scholar
• Nagy G, Matti U, Nehring RB et al. Protein kinase C-dependent phosphorylation of synaptosome-associated protein of 25 kDa at Ser187 potentiates vesicle recruitment. J. Neurosci.22, 9278–9286 (2002).
   Google Scholar
• Barclay JW, Craig TJ, Fisher RJ et al. Phosphorylation of Munc18 by protein kinase C regulates the kinetics of exocytosis. J. Biol. Chem.278, 10538–10545 (2003).
   Google Scholar
• Takayama S, White MF, Kahn CR. Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity. J. Biol. Chem.263, 3440–3447 (1988).
   PubMedGoogle Scholar
• Yu C, Chen Y, Cline GW et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1) -associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem.277, 50230–50236 (2002).
   PubMed Web of Science ®Google Scholar
• Osada S, Mizuno K, Saido TC, Suzuki K, Kuroki T, Ohno S. A new member of the protein kinase C family, nPKC θ, predominantly expressed in skeletal muscle. Mol. Cell Biol.12, 3930–3938 (1992).
   PubMed Web of Science ®Google Scholar
• Chang JD, Xu J, Raychowdhury MK, Ware JA. Molecular cloning and expression of a cDNA encoding a novel isoenzyme of protein kinase C (nPKC). A new member of the nPKC family expressed in skeletal muscle, megakaryoblastic cells, and platelets. J. Biol. Chem.268, 14208–14214 (1993).
   PubMed Web of Science ®Google Scholar
• Donnelly R, Reed MJ, Azhar S, Reaven GM. Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology135, 2369–2374 (1994).
   PubMed Web of Science ®Google Scholar
• Qu X, Seale JP, Donnelly R. Tissue and isoform-selective activation of protein kinase C in insulin-resistant obese Zucker rats – effects of feeding. J. Endocrinol.162, 207–214 (1999).
   PubMedGoogle Scholar
• Kim JK, Fillmore JJ, Sunshine MJ et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J. Clin. Invest.114, 823–827 (2004).
   PubMed Web of Science ®Google Scholar
• Haasch D, Berg C, Clampit JE et al. PKCθ is a key player in the development of insulin resistance. Biochem. Biophys. Res. Commun.343, 361–368 (2006).
   Google Scholar
• Shoelson SE, Lee J, Yuan M. Inflammation and the IKK-β/I κ B/NF-κ B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord.27, S49–S52 (2003).
   PubMed Web of Science ®Google Scholar
• Boden G, She P, Mozzoli M et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-κB pathway in rat liver. Diabetes54, 3458–3465 (2005).
   PubMed Web of Science ®Google Scholar
• Cai D, Yuan M, Frantz DFet al.Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat. Med.11, 183–190 (2005).
   PubMed Web of Science ®Google Scholar
• Yuan M, Konstantopoulos N, Lee J et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikκ. Science293, 1673–1677 (2001).
   PubMed Web of Science ®Google Scholar
• Hundal RS, Petersen KF, Mayerson AB et al. Mechanism by which high-dose aspirin improves glucose metabolism in Type 2 diabetes. J. Clin. Invest.109, 1321–1326 (2002).
   PubMed Web of Science ®Google Scholar
• Arkan MC, Hevener AL, Greten FR et al. IKK-β links inflammation to obesity-induced insulin resistance. Nat. Med.11, 191–198 (2005).
   PubMed Web of Science ®Google Scholar
• Kim JK, Kim YJ, Fillmore JJ et al. Prevention of fat-induced insulin resistance by salicylate. J. Clin. Invest.108, 437–446 (2001).
   PubMed Web of Science ®Google Scholar
• Gao Z, Hwang D, Bataille F et al. Serine phosphorylation of insulin receptor substrate 1 by inhibitor κB kinase complex. J. Biol. Chem.277, 48115–48121 (2002).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science259, 87–91 (1993).
   PubMed Web of Science ®Google Scholar
• Barzilay JI, Freedland ES. Inflammation and its relationship to insulin resistance, Type 2 diabetes mellitus, and endothelial dysfunction. Metabolic Syndrome1, 55–67 (2003).
   Google Scholar
• Festa A, D’Agostino R Jr, Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of Type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes51, 1131–1137 (2002).
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord.27, S53–S55 (2003).
   PubMed Web of Science ®Google Scholar
• Moller DE. Potential role of TNF-α in the pathogenesis of insulin resistance and Type 2 diabetes. Trends Endocrinol. Metab.11, 212–217 (2000).
   PubMed Web of Science ®Google Scholar
• Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am. J. Physiol. Endocrinol. Metab.280, E745–E751 (2001).
   PubMed Web of Science ®Google Scholar
• Tsigos C, Kyrou I, Chala E et al. Circulating tumor necrosis factor α concentrations are higher in abdominal versus peripheral obesity. Metabolism48, 1332–1335 (1999).
   PubMed Web of Science ®Google Scholar
• Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes52, 2784–2789 (2003).
   PubMed Web of Science ®Google Scholar
• Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-α, overexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem.278, 45777–45784 (2003).
   PubMed Web of Science ®Google Scholar
• Lagathu C, Bastard JP, Auclair M, Maachi M, Capeau J, Caron M. Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. Biochem. Biophys. Res. Commun.311, 372–379 (2003).
   PubMed Web of Science ®Google Scholar
• Kim HJ et al. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes53, 1060–1067 (2004).
   PubMed Web of Science ®Google Scholar
• Patel SD, Rajala MW, Rossetti L, Scherer PE, Shapiro L. Disulfide-dependent multimeric assembly of resistin family hormones. Science304, 1154–1158 (2004).
   PubMed Web of Science ®Google Scholar
• Rondinone CM. Adipocyte-derived hormones, cytokines, and mediators. Endocrine29, 81–90 (2006).
   PubMed Web of Science ®Google Scholar
• Kushiyama A, Shojima N, Ogihara T et al. Resistin-like molecule β activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J. Biol. Chem.280, 42016–42025 (2005).
   Google Scholar
• Fujishiro M, Gotoh Y, Katagiri H et al. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes Mol. Endocrinol.17, 487–497 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature372, 425–432 (1994).
   PubMed Web of Science ®Google Scholar
• Leibel RL. The role of leptin in the control of body weight. Nutr. Rev.60, S15–S19 (2002).
   PubMed Web of Science ®Google Scholar
• Ahima RS, Flier JS. Leptin. Annu. Rev. Physiol.62, 413–437 (2000).
   PubMed Web of Science ®Google Scholar
• Toyoshima Y, Gavrilova O, Yakar S et al. Leptin improves insulin resistance and hyperglycemia in a mouse model of Type 2 diabetes. Endocrinology146, 4024–4035 (2005).
   PubMedGoogle Scholar
• Minokoshi Y, Kim YB, Peroni OD et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature415, 339–343 (2002).
   PubMed Web of Science ®Google Scholar
• Bjorbaek C, Kahn BB. Leptin signaling in the central nervous system and the periphery. Recent Prog. Horm. Res.59, 305–331 (2004).
   PubMedGoogle Scholar
• Brabant G, Muller G, Horn R, Anderwald C, Roden M, Nave H. Hepatic leptin signaling in obesity. FASEB J.19, 1048–1050 (2005).
   Google Scholar
• Nogalska A, Sucajtys-Szulc E, Swierczynski J. Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metabolism54, 1041–1047 (2005).
   PubMed Web of Science ®Google Scholar
• Biddinger SB, Miyazaki M, Boucher J, Ntambi JM, Kahn CR. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes55, 2032–2041 (2006).
   PubMed Web of Science ®Google Scholar
• Fruebis J, Tsao TS, Javorschi S et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl Acad. Sci. USA.98, 2005–2010 (2001).
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med.7, 941–946 (2001).
   PubMed Web of Science ®Google Scholar
• Nawrocki AR, Rajala MW, Tomas E. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor γ agonists. J. Biol. Chem.281, 2654–2660 (2006).
   PubMed Web of Science ®Google Scholar
• Kubota N, Terauchi Y, Yamauchi T et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem.277, 25863–25866 (2002).
   PubMed Web of Science ®Google Scholar
• Maeda N, Shimomura I, Kishida K et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med.8, 731–737 (2002).
   PubMed Web of Science ®Google Scholar
• Combs TP, Pajvani UB, Berg AH et al. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology145, 367–383 (2004).
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H et al. Globular adiponectin protected ob/ob mice from diabetes and apoE-deficient mice from atherosclerosis. J. Biol. Chem.278, 2461–2468 (2003).
   PubMed Web of Science ®Google Scholar
• Tomas E, Tsao TS, Saha AK et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl Acad. Sci. USA99, 16309–16313 (2002).
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Minokoshi Y et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med.8, 1288–1295 (2002).
   PubMed Web of Science ®Google Scholar
• Andreelli F, Foretz M, Knauf C et al. Liver adenosine monophosphate-activated kinase-α2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin. Endocrinology147, 2432–2441 (2006).
   PubMed Web of Science ®Google Scholar
• Bajaj M, Suraamornkul S, Piper P et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated Type 2 diabetes patients. J. Clin. Endocrinol. Metab.89, 200–206 (2004).
   PubMed Web of Science ®Google Scholar
• Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am. J. Clin. Nutr.76, 911–922 (2002).
   PubMed Web of Science ®Google Scholar
• Hamman RF. Genetic and environmental determinants of non-insulin dependent diabetes mellitus (NIDDM). Diabetes Metab. Rev.8, 287–338 (1992).
   PubMed Web of Science ®Google Scholar
• Pagliassotti MJ, Prach PA, Koppenhafer TA, Pan DA. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am. J. Physiol.271, R1319–R1326 (1996).
   PubMed Web of Science ®Google Scholar
• Wei Y, Pagliassotti MJ. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. Am. J. Physiol.287, E926–E933 (2004).
   Google Scholar
• Aguirre V, Werner ED, Giraud J, Lee YH, Shoelson SE, White MF. Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J. Biol. Chem.277, 1531–1537 (2002).
   PubMed Web of Science ®Google Scholar
• Dirlewanger M, Schneiter P, Jequier E, Tappy L. Effects of fructose on hepatic glucose metabolism in humans. Am. J. Physiol.279, E907–E911 (2000).
   PubMed Web of Science ®Google Scholar
• Wei Y, Wang D, Pagliassotti MJ. Fructose selectively modulates c-jun N-terminal kinase activity and insulin signaling in rat Primary hepatocytes. J. Nutr.135, 1642–1646 (2005).
   PubMed Web of Science ®Google Scholar
• Wei Y, Pagliassotti MJ. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. Am. J. Physiol.287, E926–E933 (2004).
   PubMed Web of Science ®Google Scholar
• Bezerra RMN, Ueno M, Silva MS, Tavares DQ, Carvalho CRO, Saad MF. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J. Nutr.130, 1531–1535 (2000).
   PubMed Web of Science ®Google Scholar
• Kelley GL, Allan G, Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology145, 548–555 (2004).
   PubMed Web of Science ®Google Scholar
• Faeh D, Minehira K, Schwarz JM, Perasami R, Seongsu P, Tappy L. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes54, 1907–13 (2005).
   PubMed Web of Science ®Google Scholar
• Um SH, D’Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab.3, 393–402 (2006).
   Google Scholar
• Um SH, Frigerio F, Watanabe M et al. Absence of (S6K1) protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature431, 200–205 (2004).
   PubMed Web of Science ®Google Scholar
• Harrington LS, Findlay GM, Gray A et al. The TSC1–2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell. Biol.166, 213–223 (2004).
   PubMed Web of Science ®Google Scholar
• Khamzina L, Veilleux A, Bergeron S, Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology146, 1473–1481 (2005).
   PubMed Web of Science ®Google Scholar
• Tremblay F, Krebs M, Dombrowski L et al. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes54, 2674–2684 (2005).
   PubMed Web of Science ®Google Scholar
• Cohen P. Protein kinases – the major drug targets of the twenty-first century? Nat. Rev. Drug Discov.1, 309–315 (2002).
   PubMed Web of Science ®Google Scholar
• Pawson T, Nash P. Protein–protein interactions define specificity in signal transduction. Genes Dev.14, 1027–1047 (2000).
   PubMed Web of Science ®Google Scholar